Literature DB >> 19278725

Dicer and outcomes in patients with acute myeloid leukemia (AML).

Mike G Martin, Jacqueline E Payton, Daniel C Link.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19278725     DOI: 10.1016/j.leukres.2009.02.003

Source DB:  PubMed          Journal:  Leuk Res        ISSN: 0145-2126            Impact factor:   3.156


× No keyword cloud information.
  13 in total

1.  DICER1 expression and outcomes in endometrioid endometrial adenocarcinoma.

Authors:  Israel Zighelboim; Andrew J Reinhart; Feng Gao; Amy P Schmidt; David G Mutch; Premal H Thaker; Paul J Goodfellow
Journal:  Cancer       Date:  2010-11-08       Impact factor: 6.860

2.  Dicer1, AGO3, and AGO4 microRNA machinery genes are differentially expressed in developing female reproductive organs and overexpressed in cancerous ovaries of chickens.

Authors:  W Jeong; H Bae; W Lim; G Song
Journal:  J Anim Sci       Date:  2017-11       Impact factor: 3.159

3.  Upregulation of Dicer is more frequent in monoclonal gammopathies of undetermined significance than in multiple myeloma patients and is associated with longer survival in symptomatic myeloma patients.

Authors:  María E Sarasquete; Norma C Gutiérrez; Irena Misiewicz-Krzeminska; Bruno Paiva; María C Chillón; Miguel Alcoceba; Ramón García-Sanz; Jesús M Hernández; Marcos González; Jesús F San-Miguel
Journal:  Haematologica       Date:  2010-12-15       Impact factor: 9.941

4.  Down-regulation of Dicer in hepatocellular carcinoma.

Authors:  Jin-Feng Wu; Wei Shen; Nian-Zhou Liu; Gui-Li Zeng; Mei Yang; Guo-Qing Zuo; Xiu-Ni Gan; Hong Ren; Kai-Fu Tang
Journal:  Med Oncol       Date:  2010-04-20       Impact factor: 3.064

5.  Complexity in regulation of microRNA machinery components in invasive breast carcinoma.

Authors:  Sun Young Kwon; Jae-ho Lee; Bora Kim; Jong-Wook Park; Taeg Kyu Kwon; Sun Hee Kang; Shin Kim
Journal:  Pathol Oncol Res       Date:  2014-02-27       Impact factor: 3.201

6.  TLR9-mediated siRNA delivery for targeting of normal and malignant human hematopoietic cells in vivo.

Authors:  Qifang Zhang; Dewan Md Sakib Hossain; Sergey Nechaev; Anna Kozlowska; Wang Zhang; Yong Liu; Claudia M Kowolik; Piotr Swiderski; John J Rossi; Stephen Forman; Sumanta Pal; Ravi Bhatia; Andrew Raubitschek; Hua Yu; Marcin Kortylewski
Journal:  Blood       Date:  2013-01-03       Impact factor: 22.113

Review 7.  DICER1: mutations, microRNAs and mechanisms.

Authors:  William D Foulkes; John R Priest; Thomas F Duchaine
Journal:  Nat Rev Cancer       Date:  2014-09-01       Impact factor: 60.716

8.  Dicer expression in estrogen receptor-positive versus triple-negative breast cancer: an antibody comparison.

Authors:  Nicole S Spoelstra; Diana M Cittelly; Jessica L Christenson; Michael A Gordon; Anthony Elias; Paul Jedlicka; Jennifer K Richer
Journal:  Hum Pathol       Date:  2016-05-31       Impact factor: 3.466

9.  Clinicopathological and prognostic significance of the microRNA processing enzyme DICER1 mRNA expression in colorectal cancer patients.

Authors:  Takuya Akahane
Journal:  Mol Clin Oncol       Date:  2012-11-22

10.  Stop the dicing in hematopoiesis: what have we learned?

Authors:  Mir Farshid Alemdehy; Stefan J Erkeland
Journal:  Cell Cycle       Date:  2012-08-01       Impact factor: 4.534

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.